General Manager And Pharmacist In Charg
Driving force behind the seamless migration of the business into a new facility in Dayton, New Jersey in October 2015 Close monitoring of all activities associated with sterile products compounding and coordination of activities for several departments in charge of production, quality assurance, and product distribution Facilitation of discussion regarding all issues, key performance indicators (KPIs), and opportunities during daily mandatory production and quality meetings Planning and execution of weekly Gemba walks to determine Lean six sigma opportunities Thorough evaluation of all financial statements; sales and activity and quality reports; and performance data to gage productivity and goal achievement, as well as to identify areas requiring cost reduction and program improvement Responsibility in guaranteeing all team members are up to date with Current Good Manufacturing practices (cGMP) training, standard operating procedure (SOP) training, and qualifications by scheduling monthly meetings with department heads and facility trainers Instrumental in bringing the following key business impacts: Growth of the employee headcount, from 55 to 298 full-time equivalent staff between October 2015 and February 2020; and Significant increase of the daily production from 14,000 to 46,000 units Accountability in obtaining all personal licenses required for business continuity, including the Drug Enforcement Administration (DEA) license within the first year of employment that enabled the business to compound controlled substances and progressed from a one-shift to a three-shift operation